TD5A:FRA
Tandem Diabetes Care Inc
€13.90
arrow_downward
-1.42%(-0.20) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TD5A...
Open
€13.90
High
€13.90
Low
€13.90
Mkt. cap
1.12B
Avg. vol.
8.00
Volume
0.00
52-wk high
€23.09
52-wk low
€10.90
No. of employees
2K
Open
€13.90
High
€13.90
Low
€13.90
Mkt. cap
1.12B
Avg. vol.
8.00
Volume
0.00
52-wk high
€23.09
52-wk low
€10.90
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
2 days ago
Barclays keeps Tandem Diabetes Care stock at Hold with USD 18.00 target
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com